Targeted Prostate Cancer Therapy Cuts Side-Effect Risk, NHS Trial Finds

A 10-year NHS trial involving nearly 3,500 men found that focal therapy — a less invasive prostate cancer treatment targeting only the affected area of the gland — significantly cuts the risk of serious side effects compared to conventional treatments. The study is one of the largest of its kind and supports wider use of the approach. Focal therapy spares healthy surrounding tissue, reducing complications such as incontinence and impotence.

More on this topic

🏥 Health Minimally invasive prostate cancer treatment proves equally effective with fewer complications PAP Nauka · 6d ago 🏥 Health New antibody drug halts aggressive prostate cancer spread in preclinical tests Science Daily · 7d ago 🔬 Science Rare gene mutation linked to aggressive hereditary prostate cancer identified TVN24 · 13d ago

More on this topic

🏥 Health Minimally invasive prostate cancer treatment proves equally effective with fewer complications PAP Nauka · 6d ago 🏥 Health New antibody drug halts aggressive prostate cancer spread in preclinical tests Science Daily · 7d ago 🔬 Science Rare gene mutation linked to aggressive hereditary prostate cancer identified TVN24 · 13d ago